Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 41 entries
Sorted by: Best Match Show Resources per page
MicroRNA 150-5p Improves Risk Classification for Mortality within 90 Days after Acute Ischemic Stroke.

Journal of stroke

Scherrer N, Fays F, Mueller B, Luft A, Fluri F, Christ-Crain M, Devaux Y, Katan M.
PMID: 29037006
J Stroke. 2017 Sep;19(3):323-332. doi: 10.5853/jos.2017.00423. Epub 2017 Sep 29.

BACKGROUND AND PURPOSE: Micro ribonucleic acid-150-5p (miR-150-5p) regulates proinflammatory cytokines as well as vessel integrity. We evaluated the incremental prognostic value of logarithm (log) of miR-150-5p plasma levels after ischemic stroke.METHODS: In a prospective cohort study, levels of miR-150-5p...

Cite
Scherrer N, Fays F, Mueller B, et al. MicroRNA 150-5p Improves Risk Classification for Mortality within 90 Days after Acute Ischemic Stroke. J Stroke. 2017;19(3):323-332doi: 10.5853/jos.2017.00423.
Scherrer, N., Fays, F., Mueller, B., Luft, A., Fluri, F., Christ-Crain, M., Devaux, Y., & Katan, M. (2017). MicroRNA 150-5p Improves Risk Classification for Mortality within 90 Days after Acute Ischemic Stroke. Journal of stroke, 19(3), 323-332. https://doi.org/10.5853/jos.2017.00423
Scherrer, Natalie, et al. "MicroRNA 150-5p Improves Risk Classification for Mortality within 90 Days after Acute Ischemic Stroke." Journal of stroke vol. 19,3 (2017): 323-332. doi: https://doi.org/10.5853/jos.2017.00423
Scherrer N, Fays F, Mueller B, Luft A, Fluri F, Christ-Crain M, Devaux Y, Katan M. MicroRNA 150-5p Improves Risk Classification for Mortality within 90 Days after Acute Ischemic Stroke. J Stroke. 2017 Sep;19(3):323-332. doi: 10.5853/jos.2017.00423. Epub 2017 Sep 29. PMID: 29037006; PMCID: PMC5647633.
Copy Download .nbib Format: NLM
Procalcitonin and pneumonia: is it a useful marker?.

Current infectious disease reports

Christ-Crain M, Müller B.
PMID: 17430706
Curr Infect Dis Rep. 2007 May;9(3):233-40. doi: 10.1007/s11908-007-0037-9.

An ideal biomarker for pneumonia should allow an early diagnosis and differential diagnosis from noninfectious conditions and should inform about the course and prognosis of the disease. Procalcitonin (PCT) covers these features better as compared to more commonly used...

Cite
Christ-Crain M, Müller B. Procalcitonin and pneumonia: is it a useful marker?. Curr Infect Dis Rep. 2007;9(3):233-40doi: 10.1007/s11908-007-0037-9.
Christ-Crain, M., & Müller, B. (2007). Procalcitonin and pneumonia: is it a useful marker?. Current infectious disease reports, 9(3), 233-40. https://doi.org/10.1007/s11908-007-0037-9
Christ-Crain, Mirjam, and Müller, Beat. "Procalcitonin and pneumonia: is it a useful marker?." Current infectious disease reports vol. 9,3 (2007): 233-40. doi: https://doi.org/10.1007/s11908-007-0037-9
Christ-Crain M, Müller B. Procalcitonin and pneumonia: is it a useful marker?. Curr Infect Dis Rep. 2007 May;9(3):233-40. doi: 10.1007/s11908-007-0037-9. PMID: 17430706.
Copy Download .nbib Format: NLM
Pituitary Disease in Pregnancy: Special Aspects of Diagnosis and Treatment?.

Geburtshilfe und Frauenheilkunde

Petersenn S, Christ-Crain M, Droste M, Finke R, Flitsch J, Kreitschmann-Andermahr I, Luger A, Schopohl J, Stalla G.
PMID: 31000881
Geburtshilfe Frauenheilkd. 2019 Apr;79(4):365-374. doi: 10.1055/a-0794-7587. Epub 2019 Mar 06.

The diagnosis and treatment of pituitary disease in pregnancy represents a special clinical challenge. Not least because there is very little data on the treatment of pregnant patients with pituitary disorders. A selective search of the literature was carried...

Cite
Petersenn S, Christ-Crain M, Droste M, et al. Pituitary Disease in Pregnancy: Special Aspects of Diagnosis and Treatment?. Geburtshilfe Frauenheilkd. 2019;79(4):365-374doi: 10.1055/a-0794-7587.
Petersenn, S., Christ-Crain, M., Droste, M., Finke, R., Flitsch, J., Kreitschmann-Andermahr, I., Luger, A., Schopohl, J., & Stalla, G. (2019). Pituitary Disease in Pregnancy: Special Aspects of Diagnosis and Treatment?. Geburtshilfe und Frauenheilkunde, 79(4), 365-374. https://doi.org/10.1055/a-0794-7587
Petersenn, Stephan, et al. "Pituitary Disease in Pregnancy: Special Aspects of Diagnosis and Treatment?." Geburtshilfe und Frauenheilkunde vol. 79,4 (2019): 365-374. doi: https://doi.org/10.1055/a-0794-7587
Petersenn S, Christ-Crain M, Droste M, Finke R, Flitsch J, Kreitschmann-Andermahr I, Luger A, Schopohl J, Stalla G. Pituitary Disease in Pregnancy: Special Aspects of Diagnosis and Treatment?. Geburtshilfe Frauenheilkd. 2019 Apr;79(4):365-374. doi: 10.1055/a-0794-7587. Epub 2019 Mar 06. PMID: 31000881; PMCID: PMC6461462.
Copy Download .nbib Format: NLM
Effects of interleukin-1 antagonism on cortisol levels in individuals with obesity: a randomized clinical trial.

Endocrine connections

Ebrahimi F, Urwyler SA, Schuetz P, Mueller B, Bernasconi L, Neyer P, Donath MY, Christ-Crain M.
PMID: 31042669
Endocr Connect. 2019 Jun 01;8(6):701-708. doi: 10.1530/EC-19-0201.

BACKGROUND: Anti-inflammatory treatment with interleukin-1 (IL-1) antagonism decreases both cortisol and adrenocorticotropin hormone (ACTH) levels in individuals with obesity in short term. However, it remains unknown whether these effects persist upon prolonged treatment.METHODS: In this double-blind, parallel-group trial involving...

Cite
Ebrahimi F, Urwyler SA, Schuetz P, et al. Effects of interleukin-1 antagonism on cortisol levels in individuals with obesity: a randomized clinical trial. Endocr Connect. 2019;8(6):701-708doi: 10.1530/EC-19-0201.
Ebrahimi, F., Urwyler, S. A., Schuetz, P., Mueller, B., Bernasconi, L., Neyer, P., Donath, M. Y., & Christ-Crain, M. (2019). Effects of interleukin-1 antagonism on cortisol levels in individuals with obesity: a randomized clinical trial. Endocrine connections, 8(6), 701-708. https://doi.org/10.1530/EC-19-0201
Ebrahimi, Fahim, et al. "Effects of interleukin-1 antagonism on cortisol levels in individuals with obesity: a randomized clinical trial." Endocrine connections vol. 8,6 (2019): 701-708. doi: https://doi.org/10.1530/EC-19-0201
Ebrahimi F, Urwyler SA, Schuetz P, Mueller B, Bernasconi L, Neyer P, Donath MY, Christ-Crain M. Effects of interleukin-1 antagonism on cortisol levels in individuals with obesity: a randomized clinical trial. Endocr Connect. 2019 Jun 01;8(6):701-708. doi: 10.1530/EC-19-0201. PMID: 31042669; PMCID: PMC6547405.
Copy Download .nbib Format: NLM
Effects of oral macimorelin on copeptin and anterior pituitary hormones in healthy volunteers.

Pituitary

Urwyler SA, Lustenberger S, Drummond JR, Soares BS, Vogt DR, Ammer N, Yuen KCJ, Ribeiro-Oliveira A, Christ-Crain M.
PMID: 33615399
Pituitary. 2021 Aug;24(4):555-563. doi: 10.1007/s11102-021-01132-9. Epub 2021 Feb 22.

PURPOSE: The test with the highest diagnostic accuracy for diabetes insipidus is copeptin measurement after hypertonic saline infusion. However, the procedure is cumbersome and unpleasant due to rapid sodium increase. An oral stimulation test would be highly desirable. Macimorelin,...

Cite
Urwyler SA, Lustenberger S, Drummond JR, et al. Effects of oral macimorelin on copeptin and anterior pituitary hormones in healthy volunteers. Pituitary. 2021;24(4):555-563doi: 10.1007/s11102-021-01132-9.
Urwyler, S. A., Lustenberger, S., Drummond, J. R., Soares, B. S., Vogt, D. R., Ammer, N., Yuen, K. C. J., Ribeiro-Oliveira, A., & Christ-Crain, M. (2021). Effects of oral macimorelin on copeptin and anterior pituitary hormones in healthy volunteers. Pituitary, 24(4), 555-563. https://doi.org/10.1007/s11102-021-01132-9
Urwyler, Sandrine A, et al. "Effects of oral macimorelin on copeptin and anterior pituitary hormones in healthy volunteers." Pituitary vol. 24,4 (2021): 555-563. doi: https://doi.org/10.1007/s11102-021-01132-9
Urwyler SA, Lustenberger S, Drummond JR, Soares BS, Vogt DR, Ammer N, Yuen KCJ, Ribeiro-Oliveira A, Christ-Crain M. Effects of oral macimorelin on copeptin and anterior pituitary hormones in healthy volunteers. Pituitary. 2021 Aug;24(4):555-563. doi: 10.1007/s11102-021-01132-9. Epub 2021 Feb 22. PMID: 33615399; PMCID: PMC8270818.
Copy Download .nbib Format: NLM
Impact of Adrenal Function on Hemostasis/Endothelial Function in Patients Undergoing Surgery.

Journal of the Endocrine Society

Fischli S, von Wyl V, Wuillemin W, von Känel R, Schütz P, Christ-Crain M, Studer F, Brander L, Schüpfer G, Metzger J, Henzen C.
PMID: 33928206
J Endocr Soc. 2021 Mar 23;5(5):bvab047. doi: 10.1210/jendso/bvab047. eCollection 2021 May 01.

CONTEXT: Glucocorticoids regulate hemostatic and endothelial function, and they are critical for adaptive functions during surgery. No data regarding the impact of adrenal function on hemostasis and endothelial function in the perioperative setting are available.OBJECTIVE: We assessed the association...

Cite
Fischli S, von Wyl V, Wuillemin W, et al. Impact of Adrenal Function on Hemostasis/Endothelial Function in Patients Undergoing Surgery. J Endocr Soc. 2021;5(5):bvab047doi: 10.1210/jendso/bvab047.
Fischli, S., von Wyl, V., Wuillemin, W., von Känel, R., Schütz, P., Christ-Crain, M., Studer, F., Brander, L., Schüpfer, G., Metzger, J., & Henzen, C. (2021). Impact of Adrenal Function on Hemostasis/Endothelial Function in Patients Undergoing Surgery. Journal of the Endocrine Society, 5(5), bvab047. https://doi.org/10.1210/jendso/bvab047
Fischli, Stefan, et al. "Impact of Adrenal Function on Hemostasis/Endothelial Function in Patients Undergoing Surgery." Journal of the Endocrine Society vol. 5,5 (2021): bvab047. doi: https://doi.org/10.1210/jendso/bvab047
Fischli S, von Wyl V, Wuillemin W, von Känel R, Schütz P, Christ-Crain M, Studer F, Brander L, Schüpfer G, Metzger J, Henzen C. Impact of Adrenal Function on Hemostasis/Endothelial Function in Patients Undergoing Surgery. J Endocr Soc. 2021 Mar 23;5(5):bvab047. doi: 10.1210/jendso/bvab047. eCollection 2021 May 01. PMID: 33928206; PMCID: PMC8057135.
Copy Download .nbib Format: NLM
Impact of Adrenal Function on Hemostasis/Endothelial Function in Patients Undergoing Surgery.

Journal of the Endocrine Society

Fischli S, von Wyl V, Wuillemin W, von Känel R, Schütz P, Christ-Crain M, Studer F, Brander L, Schüpfer G, Metzger J, Henzen C.
PMID: 33928206
J Endocr Soc. 2021 Mar 23;5(5):bvab047. doi: 10.1210/jendso/bvab047. eCollection 2021 May 01.

CONTEXT: Glucocorticoids regulate hemostatic and endothelial function, and they are critical for adaptive functions during surgery. No data regarding the impact of adrenal function on hemostasis and endothelial function in the perioperative setting are available.OBJECTIVE: We assessed the association...

Cite
Fischli S, von Wyl V, Wuillemin W, et al. Impact of Adrenal Function on Hemostasis/Endothelial Function in Patients Undergoing Surgery. J Endocr Soc. 2021;5(5):bvab047doi: 10.1210/jendso/bvab047.
Fischli, S., von Wyl, V., Wuillemin, W., von Känel, R., Schütz, P., Christ-Crain, M., Studer, F., Brander, L., Schüpfer, G., Metzger, J., & Henzen, C. (2021). Impact of Adrenal Function on Hemostasis/Endothelial Function in Patients Undergoing Surgery. Journal of the Endocrine Society, 5(5), bvab047. https://doi.org/10.1210/jendso/bvab047
Fischli, Stefan, et al. "Impact of Adrenal Function on Hemostasis/Endothelial Function in Patients Undergoing Surgery." Journal of the Endocrine Society vol. 5,5 (2021): bvab047. doi: https://doi.org/10.1210/jendso/bvab047
Fischli S, von Wyl V, Wuillemin W, von Känel R, Schütz P, Christ-Crain M, Studer F, Brander L, Schüpfer G, Metzger J, Henzen C. Impact of Adrenal Function on Hemostasis/Endothelial Function in Patients Undergoing Surgery. J Endocr Soc. 2021 Mar 23;5(5):bvab047. doi: 10.1210/jendso/bvab047. eCollection 2021 May 01. PMID: 33928206; PMCID: PMC8057135.
Copy Download .nbib Format: NLM
Impact of Sodium Levels on Functional Outcomes in Patients with Stroke - A Swiss Stroke Registry Analysis.

The Journal of clinical endocrinology and metabolism

Potasso L, Refardt J, De Marchis GM, Wiencierz A, Wright PR, Wagner B, Dittrich T, Polymeris AA, Gensicke H, Bonati LH, Christ-Crain M.
PMID: 34480576
J Clin Endocrinol Metab. 2021 Sep 04; doi: 10.1210/clinem/dgab650. Epub 2021 Sep 04.

CONTEXT: Correction of hyponatremia might represent an additional treatment for improving stroke patients' clinical outcomes.OBJECTIVE: Admission hyponatremia is associated with worse clinical outcome in stroke patients, but whether normalization of hyponatremia improves outcome is unknown. We investigated whether normalization...

Cite
Potasso L, Refardt J, De Marchis GM, et al. Impact of Sodium Levels on Functional Outcomes in Patients with Stroke - A Swiss Stroke Registry Analysis. J Clin Endocrinol Metab. 2021;doi: 10.1210/clinem/dgab650.
Potasso, L., Refardt, J., De Marchis, G. M., Wiencierz, A., Wright, P. R., Wagner, B., Dittrich, T., Polymeris, A. A., Gensicke, H., Bonati, L. H., & Christ-Crain, M. (2021). Impact of Sodium Levels on Functional Outcomes in Patients with Stroke - A Swiss Stroke Registry Analysis. The Journal of clinical endocrinology and metabolism, . https://doi.org/10.1210/clinem/dgab650
Potasso, Laura, et al. "Impact of Sodium Levels on Functional Outcomes in Patients with Stroke - A Swiss Stroke Registry Analysis." The Journal of clinical endocrinology and metabolism vol. (2021). doi: https://doi.org/10.1210/clinem/dgab650
Potasso L, Refardt J, De Marchis GM, Wiencierz A, Wright PR, Wagner B, Dittrich T, Polymeris AA, Gensicke H, Bonati LH, Christ-Crain M. Impact of Sodium Levels on Functional Outcomes in Patients with Stroke - A Swiss Stroke Registry Analysis. J Clin Endocrinol Metab. 2021 Sep 04; doi: 10.1210/clinem/dgab650. Epub 2021 Sep 04. PMID: 34480576.
Copy Download .nbib Format: NLM
Impact of Sodium Levels on Functional Outcomes in Patients With Stroke - A Swiss Stroke Registry Analysis.

The Journal of clinical endocrinology and metabolism

Potasso L, Refardt J, De Marchis GM, Wiencierz A, Wright PR, Wagner B, Dittrich T, Polymeris AA, Gensicke H, Bonati LH, Christ-Crain M.
PMID: 34480576
J Clin Endocrinol Metab. 2022 Jan 18;107(2):e672-e680. doi: 10.1210/clinem/dgab650.

CONTEXT: Correction of hyponatremia might represent an additional treatment for improving stroke patients' clinical outcomes.OBJECTIVE: Admission hyponatremia is associated with worse clinical outcome in stroke patients, but whether normalization of hyponatremia improves outcome is unknown. We investigated whether normalization...

Cite
Potasso L, Refardt J, De Marchis GM, et al. Impact of Sodium Levels on Functional Outcomes in Patients With Stroke - A Swiss Stroke Registry Analysis. J Clin Endocrinol Metab. 2022;107(2):e672-e680doi: 10.1210/clinem/dgab650.
Potasso, L., Refardt, J., De Marchis, G. M., Wiencierz, A., Wright, P. R., Wagner, B., Dittrich, T., Polymeris, A. A., Gensicke, H., Bonati, L. H., & Christ-Crain, M. (2022). Impact of Sodium Levels on Functional Outcomes in Patients With Stroke - A Swiss Stroke Registry Analysis. The Journal of clinical endocrinology and metabolism, 107(2), e672-e680. https://doi.org/10.1210/clinem/dgab650
Potasso, Laura, et al. "Impact of Sodium Levels on Functional Outcomes in Patients With Stroke - A Swiss Stroke Registry Analysis." The Journal of clinical endocrinology and metabolism vol. 107,2 (2022): e672-e680. doi: https://doi.org/10.1210/clinem/dgab650
Potasso L, Refardt J, De Marchis GM, Wiencierz A, Wright PR, Wagner B, Dittrich T, Polymeris AA, Gensicke H, Bonati LH, Christ-Crain M. Impact of Sodium Levels on Functional Outcomes in Patients With Stroke - A Swiss Stroke Registry Analysis. J Clin Endocrinol Metab. 2022 Jan 18;107(2):e672-e680. doi: 10.1210/clinem/dgab650. PMID: 34480576.
Copy Download .nbib Format: NLM
Diabetes insipidus.

Presse medicale (Paris, France : 1983)

Christ-Crain M, Gaisl O.
PMID: 34718110
Presse Med. 2021 Dec;50(4):104093. doi: 10.1016/j.lpm.2021.104093. Epub 2021 Oct 27.

Diabetes insipidus (DI) is a disorder characterized by a high hypotonic urinary output of more than 50ml per kg body weight per 24 hours, with associated polydipsia of more than 3 liters a day [1,2]. Central DI results from...

Cite
Christ-Crain M, Gaisl O. Diabetes insipidus. Presse Med. 2021;50(4):104093doi: 10.1016/j.lpm.2021.104093.
Christ-Crain, M., & Gaisl, O. (2021). Diabetes insipidus. Presse medicale (Paris, France : 1983), 50(4), 104093. https://doi.org/10.1016/j.lpm.2021.104093
Christ-Crain, Mirjam, and Gaisl, Odile. "Diabetes insipidus." Presse medicale (Paris, France : 1983) vol. 50,4 (2021): 104093. doi: https://doi.org/10.1016/j.lpm.2021.104093
Christ-Crain M, Gaisl O. Diabetes insipidus. Presse Med. 2021 Dec;50(4):104093. doi: 10.1016/j.lpm.2021.104093. Epub 2021 Oct 27. PMID: 34718110.
Copy Download .nbib Format: NLM
Diabetes insipidus - An update in diagnosis and management.

Best practice & research. Clinical endocrinology & metabolism

Christ-Crain M.
PMID: 33222765
Best Pract Res Clin Endocrinol Metab. 2020 Sep;34(5):101470. doi: 10.1016/j.beem.2020.101470. Epub 2020 Oct 13.

No abstract available.

Cite
Christ-Crain M. Diabetes insipidus - An update in diagnosis and management. Best Pract Res Clin Endocrinol Metab. 2020;34(5):101470doi: 10.1016/j.beem.2020.101470.
Christ-Crain, M. (2020). Diabetes insipidus - An update in diagnosis and management. Best practice & research. Clinical endocrinology & metabolism, 34(5), 101470. https://doi.org/10.1016/j.beem.2020.101470
Christ-Crain, Mirjam. "Diabetes insipidus - An update in diagnosis and management." Best practice & research. Clinical endocrinology & metabolism vol. 34,5 (2020): 101470. doi: https://doi.org/10.1016/j.beem.2020.101470
Christ-Crain M. Diabetes insipidus - An update in diagnosis and management. Best Pract Res Clin Endocrinol Metab. 2020 Sep;34(5):101470. doi: 10.1016/j.beem.2020.101470. Epub 2020 Oct 13. PMID: 33222765.
Copy Download .nbib Format: NLM
The role of IL-1 in the regulation of copeptin in patients with metabolic syndrome.

Endocrine connections

Popovic M, Ebrahimi F, Urwyler SA, Donath MY, Christ-Crain M.
PMID: 32698151
Endocr Connect. 2020 Jul;9(7):715-723. doi: 10.1530/EC-20-0197.

Arginine vasopressin (AVP) was suggested to contribute to cardiovascular risk and type 2 diabetes in patients with metabolic syndrome. The proinflammatory cytokine interleukin (IL)-1 is able to induce AVP secretion and plays a causal role in cardiovascular mortality and...

Cite
Popovic M, Ebrahimi F, Urwyler SA, et al. The role of IL-1 in the regulation of copeptin in patients with metabolic syndrome. Endocr Connect. 2020;9(7):715-723doi: 10.1530/EC-20-0197.
Popovic, M., Ebrahimi, F., Urwyler, S. A., Donath, M. Y., & Christ-Crain, M. (2020). The role of IL-1 in the regulation of copeptin in patients with metabolic syndrome. Endocrine connections, 9(7), 715-723. https://doi.org/10.1530/EC-20-0197
Popovic, Milica, et al. "The role of IL-1 in the regulation of copeptin in patients with metabolic syndrome." Endocrine connections vol. 9,7 (2020): 715-723. doi: https://doi.org/10.1530/EC-20-0197
Popovic M, Ebrahimi F, Urwyler SA, Donath MY, Christ-Crain M. The role of IL-1 in the regulation of copeptin in patients with metabolic syndrome. Endocr Connect. 2020 Jul;9(7):715-723. doi: 10.1530/EC-20-0197. PMID: 32698151; PMCID: PMC7424357.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 41 entries